Skip to main content
Clinical Trials/NCT06229509
NCT06229509
Not yet recruiting
Not Applicable

Study of Cytokine Response During Exercise Dyspnea in Patients With Chronic Obstructive Pulmonary Disease (COPD). Effect of Body Composition

University Hospital, Clermont-Ferrand1 site in 1 country26 target enrollmentFebruary 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease Severe
Sponsor
University Hospital, Clermont-Ferrand
Enrollment
26
Locations
1
Primary Endpoint
Variation in exercise-induced release of cytokines IL-1, IL-6, IL-8, IL-10 and TNF-alpha plasma concentrations (pg/mL) between the two ventilatory conditions (sham and effective)
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

Dyspnea, more commonly known as breathlessness, is a symptom found in the majority of patients with chronic obstructive pulmonary disease (COPD), with a major impact on quality of life and mortality.

COPD is a chronic inflammatory disease of the bronchi, affecting 8% of the French population (more than 3 million people). By 2030, it will be the third leading cause of death worldwide. Effective management of dyspnea in these patients is a priority.

In patients with severe COPD, physical exertion increases the workload of breathing, leading to dyspnea. At the same time, the respiratory muscles and fatty cells release cytokines, myokines and adipokines - a group of proteins involved in the inflammatory response. In addition, 15% of COPD patients suffer from sarcopenia (loss of muscle mass and strength) which increases respiratory effort and dyspnea.

Our research project aims to study the effect of dyspnea relief in COPD patients on cytokine, myokine and adipokine levels, taking into account the presence of sarcopenia. Indeed, it is possible to alleviate the workload of the respiratory muscles during exercise by means of respiratory assistance.

The ultimate goal is a better understanding of dyspnea mechanisms, to enable the development of cytokine-targeted therapies and improve quality of life and survival in these patients.

Registry
clinicaltrials.gov
Start Date
February 2024
End Date
August 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Male

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years
  • Patient affiliated to a social security scheme.
  • Patient capable of giving free, informed, written and signed consent.
  • Male gender
  • Severe COPD (Chronic Obstructive Pulmonary Disease) diagnosed according to GOLD criteria, in a stable state, with a forced expiratory volume (FEV1) from 30 to 50% of the predicted value (measured within one year during respiratory function tests (RFT)
  • History of smoking \>10 pack-years with cessation of smoking for more than 12 months.
  • Patient judged by the investigator to be able to tolerate inspiratory pressure during a preliminary cycling exercise test.

Exclusion Criteria

  • Severe anxiety disorders, assessed by the STAY Y-B form questionnaire; a score above 65 indicates very high day-to-day anxiety.
  • Patient under guardianship/trusteeship/supervision of justice
  • Chronic hypercapnia at rest (CO2 arterial pressure ≥ 50mmHg)
  • Chronic use of non-invasive ventilation
  • Known pulmonary hypertension
  • Chronic administration of oral corticosteroids
  • Unstable heart disease

Outcomes

Primary Outcomes

Variation in exercise-induced release of cytokines IL-1, IL-6, IL-8, IL-10 and TNF-alpha plasma concentrations (pg/mL) between the two ventilatory conditions (sham and effective)

Time Frame: At rest = baseline / right after the end of exercice / 45 minutes after the end of exercice

Variation in exercise-induced release of adipokines adiponectin and leptin concentrations (pg/mL) between the two ventilatory conditions (sham and effective)

Time Frame: At rest = baseline / right after the end of exercice / 45 minutes after the end of exercice

Secondary Outcomes

  • For each ventilatory condition, study of correlation between fat mass (kg) and cytokines, adipokines and myokines plasma concentrations (pg/mL).(At rest = baseline / right after the end of exercice / 45 minutes after the end of exercice)
  • For each ventilatory condition, study of correlation between muscle mass (kg) and cytokines, adipokines and myokines plasma concentrations (pg/mL).(At rest = baseline / right after the end of exercice / 45 minutes after the end of exercice)
  • For each ventilatory condition, study of correlation between dyspnea descriptors (Borg scale score, Multidimensional Dyspnea Profil score) and cytokines, adipokines and myokines plasma concentrations (pg/mL)(At rest = baseline / right after the end of exercice / 45 minutes after the end of exercice)

Study Sites (1)

Loading locations...

Similar Trials